Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine vaginal gel in healthy HIV-negative women
NCT00309205Phase 2Completed
- Sponsor
- International Partnership for Microbicides
- Start
- Dec 2005
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Dapivirine Gel with Placebo Gel (2 arms). Primary endpoint: Local and systemic safety and tolerability at 42 days. Started Dec 2005; status: completed.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00309205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309205.